Cas 671781-17-2,3-Pyrazolidinone, 4-(3,4-dichlorophenyl)-2-methyl-5-(4-pyridinyl)-1-(3-pyridinylmethyl)-

671781-17-2

Post Buying Request

Basic information

Product Name: 3-Pyrazolidinone, 4-(3,4-dichlorophenyl)-2-methyl-5-(4-pyridinyl)-1-(3-pyridinylmethyl)-
Synonyms:
CAS NO:671781-17-2
Molecular Formula: C21H18Cl2N4O
Molecular Weight: 413.306
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 3-Pyrazolidinone, 4-(3,4-dichlorophenyl)-2-methyl-5-(4-pyridinyl)-1-(3-pyridinylmethyl)-(CAS DataBase Reference)
NIST Chemistry Reference: 3-Pyrazolidinone, 4-(3,4-dichlorophenyl)-2-methyl-5-(4-pyridinyl)-1-(3-pyridinylmethyl)-(671781-17-2)
EPA Substance Registry System: 3-Pyrazolidinone, 4-(3,4-dichlorophenyl)-2-methyl-5-(4-pyridinyl)-1-(3-pyridinylmethyl)-(671781-17-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 671781-17-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

671781-17-2 Suppliers

Recommended suppliers

671781-17-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 671781-17-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,1,7,8 and 1 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 671781-17:
(8*6)+(7*7)+(6*1)+(5*7)+(4*8)+(3*1)+(2*1)+(1*7)=182
182 % 10 = 2
So 671781-17-2 is a valid CAS Registry Number.

671781-17-2Upstream product

671781-17-2Downstream Products

671781-17-2Relevant academic research and scientific papers

1, 4, 5-SUBSTITUTED 1, 2-DIHYDRO-PYRAZOL-3-ONE AND 3-ALKOXY-1H-PYRAZOLE DERIVATIVES S TNF-ALPHA AND INTERLEUKIN LOWERING AGENTS FOR THE TREATMENT OF INFLAMMATIONS

-

Page/Page column 29-30, (2010/02/06)

The present invention relates to compounds having the general formula or a pharmaceutically acceptable salt thereof. Also included is a method of prophylaxis or treatment of inflammation, rheumatoid arthritis, Pagets disease, osteoporosis, multiple myelom

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 671781-17-2